Results 101 to 110 of about 2,849 (172)

Immunohistochemical Staining: Prognostic Marker of Malignant Transformation of Hydatidiform Mole (HM). [PDF]

J Obstet Gynaecol India
Chandran JR, Vijaykumar B, Aravindan KP, Rajeevan V, Shammy S.   +4 more
europepmc   +1 more source

Genomic Analysis of Low-Grade Serous Ovarian Cancer: Clinical and Biological Insights. [PDF]

Cureus
Papahliou AM, Zografos CG, Zografos E, Papatheodoridi A, Bletsa G, Domali E, Zagouri F.   +6 more
europepmc   +1 more source

Diagnostic, Prognostic, and Therapeutic Role for Angiogenesis Markers in Head and Neck Squamous Cell Carcinoma: A Narrative Review. [PDF]

Int J Mol Sci, 2023
Alessandrini L, Astolfi L, Daloiso A, Sbaraglia M, Mondello T, Zanoletti E, Franz L, Marioni G.   +7 more
europepmc   +1 more source

Activation of Nm23-H1 to suppress breast cancer metastasis via redox regulation. [PDF]

Exp Mol Med, 2021
Kim B, Lee KJ.
europepmc   +1 more source

RNA m5C modification: from physiology to pathology and its biological significance. [PDF]

Front Immunol
Chen X, Yuan Y, Zhou F, Huang X, Li L, Pu J, Zeng Y, Jiang X.   +7 more
europepmc   +1 more source

The Role of NSUN Family Genes in m5C Methylation and Diseases. [PDF]

Biomedicines
Jiang T, Jiang N, Chen X, Xiong Z.
europepmc   +1 more source

Exploring the effectiveness of molecular subtypes, biomarkers, and genetic variations as first-line treatment predictors in Asian breast cancer patients: a systematic review and meta-analysis. [PDF]

Syst Rev
Bahrin NWS, Matusin SNI, Mustapa A, Huat LZ, Perera S, Hamid MRWHA.   +5 more
europepmc   +1 more source

Cordycepin in cancer therapy: A bibliometric analysis and review of mechanisms. [PDF]

J Food Drug Anal
Ouyang Z, Zhang Y, Ning J, Tu Y, He B.
europepmc   +1 more source

The next decade of SET: from an oncoprotein to beyond. [PDF]

J Mol Cell Biol
Yao H, Zhang M, Wang D.
europepmc   +1 more source

Chimeric antigen receptor T cell therapy: Revolutionizing cancer treatment. [PDF]

World J Clin Oncol
Arjumand S, Raj A, Prattay KMR, Omer HBM, Azam F.   +4 more
europepmc   +1 more source